Global Pharmaceutical Lipid-Based Excipients Market Trends: Regional Breakdowns and Strategic Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Pharmaceutical Lipid-Based Excipients Market Through 2034?
The size of the pharmaceutical lipid-based excipients market has seen consistent expansion over recent years. The market value is projected to rise from $1.69 billion in 2024 to $1.77 billion in 2025, exemplifying a compound annual growth rate (CAGR) of 4.7%. This historic period of growth can be accredited to factors such as the increased prevalence of poorly water-soluble drugs, the growing demand for controlled and targeted drug release, amplified pharmaceutical investments, the widening utilization of oral solid dosage forms, an intensified focus on enhancing drug bioavailability, and regulatory approval of lipid excipients in innovative formulations.
Expectations are high for substantial expansion in the pharmaceutical lipid-based excipients market in the coming years. Its anticipated rise is predicted to reach $2.17 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. This projected growth during the forecast period is a consequence of an increase in demand for sophisticated drug delivery systems and a greater uptake of mRNA and gene therapies. Other influencing factors include the development of a larger pipeline for drugs with poor water solubility, a rising emphasis on personalized medicine, supportive regulatory frameworks and strategic investments in the biopharmaceutical manufacturing landscape. Trends forecasted for this period involve innovations in lipid nanoparticle delivery systems, greater use of mRNA and gene therapies, evolving solubility solutions for poorly water-soluble drugs, widening of biocompatible and sustainable lipid resources, enhanced manufacturing scalability, and broader adoption in oral and injectable formulations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Pharmaceutical Lipid-Based Excipients Market?
The increase in gene therapy practices is predicted to drive the expansion of the pharmaceutical lipid-based excipients market. Gene therapy, a medical method that modifies or manipulates an individual’s genes to prevent or treat diseases, has been increasingly adopted due to the advancements in delivery systems. These systems provide safe, efficient, and targeted transportation of genetic material into cells. Pharmaceutical lipid-based excipients contribute to the success of gene therapy by ensuring efficient delivery systems, stability, and targeted transportation of genetic material. By safeguarding the nucleic acids and promoting cellular absorption, they enhance the therapeutic results, increasing the efficiency of contemporary treatments. For instance, the American Society of Gene & Cell Therapy (ASGCT), a non-profit medical and scientific entity based in the US, highlighted in December 2024 that the Food and Drug Administration (FDA) had given approval to six gene therapy products in 2023, an increase from the five approved in the previous year. Consequently, the growth in gene therapy is fuelling the expansion of the pharmaceutical lipid-based excipients market.
Which Key Market Segments Comprise the Pharmaceutical Lipid-Based Excipients Market and Drive Its Revenue Growth?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp
Which Areas Are Leading Regions in the Pharmaceutical Lipid-Based Excipients Market Expansion Across the Globe?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Pharmaceutical Lipid-Based Excipients Industry Dynamics?
Major pharmaceutical lipid-based excipients market players are emphasizing on strategic investment opportunities such as the development of an innovative Center of Excellence. This center’s purpose is to fuel innovation, intensify formulation competencies, back drug delivery research, and solidify their market standing in new therapeutic sectors. For example, Gattefossé SAS, a France-based chemical manufacturer, inaugurated an advanced Technical Center of Excellence in Mumbai in November 2024. Aimed at supporting India’s expanding pharmaceutical market, this center offers bespoke labs and targeted support for excipient innovation. It particularly focuses on bioavailability, sustained release, and topical formulations and helps fortify its reach in the Asia-Pacific circuit. The modern facility comprises pharmaceutical and personal care application labs to boost innovation, facilitate teamwork, and generate a conducive work atmosphere.
View the full report here:
How Is the Pharmaceutical Lipid-Based Excipients Market Conceptually Defined?
Pharmaceutical lipid-based excipients are non-active (inactive) substances derived from lipids used in drug formulations to help deliver, stabilize, or enhance the absorption of the active pharmaceutical ingredient (API). Pharmaceutical lipid-based excipients aim to improve drug solubility, stability, and bioavailability, particularly for poorly water-soluble drugs.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24374
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
